Acquiring Company
Organon
Acquired Company
Tofidence
Jersey CityBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedicalDescription
Organon has announced the acquisition of Tofidence, a biosimilar approved for treating rheumatoid arthritis and other conditions. The acquisition grants Organon regulatory and commercial rights in the US. Organon will make upfront payments and assume royalty obligations based on net sales. This strategic move aims to enhance patient access to vital treatments.
Quick answer
Organon is acquiring Tofidence, announced April 14, 2025. Organon is based in Jersey City, New Jersey, United States.
- How much did Organon pay for Tofidence?
- The deal value was not disclosed.
- What does Organon do?
- Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.
- Where are Organon and Tofidence based?
- Organon is based in Jersey City, New Jersey, United States.
- Who are the decision-makers at Organon?
- Fundz holds 2 contacts at Organon. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- Merit Medical acquires BioLife hemostasis products (May 21, 2025)
- Function Health acquires Ezra for better MRI scans (May 5, 2025)
- Basel Medical Group acquires Bethesda Medical (April 30, 2025)
- Premier Biotech acquires OraSure's testing line (April 10, 2025)
- Lupin acquires UK-based Renascience Pharma (April 3, 2025)
Who to call at Organon, and when
When Organon changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Organon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Organon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Organon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Organon makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Tofidence?
Tofidence was acquired by Organon, based in Jersey City. The deal was reported on April 14, 2025. Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon is publicly traded (OGN) and operates in Biotechnology.
When did Organon acquire Tofidence?
Organon's acquisition of Tofidence was reported on April 14, 2025. Organon has announced the acquisition of Tofidence, a biosimilar approved for treating rheumatoid arthritis and other conditions. The acquisition grants Organon regulatory and commercial rights in the US. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Tofidence do?
Tofidence (tocilizumab-bavi) is a biosimilar that was approved by the FDA for various autoimmune conditions. Its commercialization is essential for providing patients with increased access to treatment options. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.